BACKGROUND: Uterine natural killer cells are the major leukocytes present in the periimplantation endometrium. Previous studies have found controversial differences in uterine natural killer cell percentage in women with recurrent reproductive failure compared with fertile controls. OBJECTIVE: We sought to compare the uterine natural killer cell percentage in women with recurrent reproductive failure and fertile controls. STUDY DESIGN: This was a retrospective study carried out in university hospitals. A total of 215 women from 3 university centers participated in the study, including 97 women with recurrent miscarriage, 34 women with recurrent implantation failure, and 84 fertile controls. Endometrial biopsy samples were obtained precisely 7 days after luteinization hormone surge in a natural cycle. Endometrial sections were immunostained for CD56 and cell counting was performed by a standardized protocol. Results were expressed as percentage of positive uterine natural killer cell/total stromal cells.
Introduction
Uterine natural killer (uNK) cells are the major leukocytes present in the endometrium. The phenotype of these uterine granulated lymphocytes in endometrium is CD56 bright CD16
e whereas in peripheral blood CD56 dim CD16
þ natural killer (NK) cells constitute the major subpopulation. 1 The number of CD56 þ NK cells varies throughout the menstrual cycle, with a dramatic increase in the midsecretory phase starting 6-7 days after the luteinizing hormone (LH) surge, the beginning of the putative time of implantation. The number of CD56 þ NK cells remains high during early pregnancy and comprises around 70% of the lymphocytes at the interface between maternal decidua and the invading trophoblast during the first trimester of pregnancy. 2 Although the increased number of uNK cells at the time of embryo implantation and their presence next to the invading trophoblast suggests that they play a role in implantation, the exact function of uNK cells is still unclear.
Studies of periimplantation endometrium have found differences in uNK cell percentage in women with recurrent reproductive failure. Using immunohistochemistry, increased percentage of CD56 þ NK cells was detected in periimplantation endometrium from women with recurrent miscarriage [3] [4] [5] and women with recurrent implantation failure after in vitro fertilization (IVF). 6, 7 Nevertheless, the prognostic value of uNK cell measurement in women with recurrent reproductive failure has not yet been confirmed. 5, 8 Furthermore, there is increasing demand from women with reproductive failure seeking uNK cell testing, despite the fact that the normal reference range of uNK cells in a fertile population has not yet been firmly established. One center used the 75th percentile of a group of 18 fertile controls as the cut-off value of 5%, 9 while another used 90th percentile of 13 fertile controls to define the upper limit, giving a value of 12.9%. 5 One of the reasons for these differences is likely to be differences in the counting methodology, which was recently resolved. 10 Given the dramatic increase in uNK cell numbers during periimplantation period, a difference in endometrial sampling time as few as 1-2 days will make a big difference to the number of uNK cells present. It is therefore important that the biopsy is precisely timed according to the LH surge and preferably taken 7 days following LH surge (LHþ7).
The aim of this study is to use the recently published methodology 10 to 
Materials and Methods Subjects
Three groups of women were recruited for this study (Table 1 ).
In the fertile control group, 72 nonsmoking Chinese women with proven fertility were recruited from Prince of Wales Hospital, Chinese University of Hong Kong and Shenzhen People's Hospital in China. Another 12 endometrial biopsies from fertile Caucasian women were collected from Sheffield Teaching Hospitals-Jessop Wing, Hallamshire Hospital, Sheffield, United Kingdom. All the women had regular menstrual cycles and had not used any hormonal treatment for at least 3 months before the biopsy. Approvals from local ethical committees in the participating centers were obtained for this study. All the endometrial biopsies were collected with the informed consent of the participants.
In the recurrent miscarriage group (n ¼ 97), endometrial biopsies were obtained from women with unexplained recurrent miscarriage attending the Recurrent Miscarriage Clinic, Prince of Wales Hospital, Chinese University of Hong Kong. Recurrent miscarriage was defined as a history of !3 consecutive miscarriages before gestational week 20, including biochemical losses. All the subjects had normal karyotyping, normal 3-dimensional ultrasonography hysterosalpingogram, day-2 folliclestimulating hormone <10 IU/L, midluteal progesterone >30 nmol/L, normal thyroid function, and tested negative for lupus anticoagulant and anticardiolipin IgG and IgM antibodies.
In the recurrent implantation failure group (n ¼ 34), endometrial biopsies were obtained from women attending the Assisted Reproductive Technology center, Prince of Wales Hospital, Chinese University of Hong Kong. Recurrent implantation failure was defined as failure to achieve a clinical pregnancy after transfer of at least 4 good-quality embryos in a minimum of 3 fresh or frozen cycles in a woman age <40 years. 11 
Endometrial biopsy
All subjects in this study had daily urine dipstick test from day 9 of the menstrual cycle onwards to identify the LH surge (ovulation), which was used to precisely time the endometrial biopsies on day LHþ7 of the periimplantation period.
All biopsies were obtained using a Pipelle sampler (Prodimed, Neuilly-enThelle, France) or Pipet Curet (Cooper Surgical, Trumbull, CT). The specimens were immediately placed into 10% neutral buffered formalin for overnight fixation at room temperature and then embedded into paraffin wax.
Immunohistochemical staining of CD56
D cells
In this study, CD56 þ immunostaining was used to determine uNK cells. No attempt was made to determine subsets of uNK cells that can be determined by differential expression of CD16.
As described in previous studies, 10, 12 paraffin-embedded human endometrial tissue sections (3 mm) were dewaxed in xylene, rehydrated through descending ethanol to Tris-buffered saline, and unmasking of antigen was performed in citrate buffer. In all cases the primary antibody used was a mouse antihuman monoclonal primary anti-CD56 antibody (NCL-CD56-504; Novocastra Laboratories, Newcastle, United Kingdom) at a 1:100 dilution. The binding of primary antibody was visualized using an avidin biotin peroxidase secondary antibody complex (Elite ABC kit; Vector Laboratories, Peterborough, United Kingdom). The slides were then incubated with peroxidase substrate 3,3'-diaminobenzidine tetrahydrochloride and 0.1% hydrogen peroxide, counterstained with hematoxylin, dehydrated through alcohols, cleared in xylene, and mounted in DPX Mountant (Sigma-Aldrich, St. Louis, MO).
Cell counting methodology
The counting method was performed according to an agreed and published standardized protocol by a multicenter working group designed to reduce variance of results between centers. 10 The number of uNK cells (CD56 þ stained) and stromal cells (CD56 e stained) were counted manually using Image J (National Institutes of Health, Rockville, MD) and the result was expressed as a percentage of total stromal cells. For cell counting, 10-Â-40 fields (at least 3800 stromal cells) were captured using a photomicroscope. The first field to be captured was selected at random, ensuring that it contained the luminal 
Intraobserver and interobserver variability
To determine the intraobserver variability, the CD56 þ cell counting was repeated by one of the observers (X.C.) on 23 blinded slides on 2 separate occasions, without knowledge of the results of the earlier measurement.
Interobserver variability for uNK cell analysis was evaluated by 2 observers (X.C. and N.M.) examining the same set of 23 randomly chosen sections using the agreed protocol, 10 independently of each other.
Statistical analysis
The data distribution was checked by the Shapiro-Wilk test. All results were presented as mean AE SD for normally distributed data or as median and range for skewed data. We used the 5th and 95th percentile results of CD56 þ cell percentage from fertile controls as the lower limit and upper limit, respectively, for the reference range. The nonparametric (Mann-Whitney U) test was used to compare percentages of CD56 þ cells in women with: (1) recurrent miscarriage and in controls; and (2) recurrent implantation failure and in controls. P < .05 was considered significant. All data were analyzed with software (SPSS 18.0; IBM Corp, Armonk, NY).
Results Demographics
All participants had regular menstrual cycles. In the fertile group, the mean age of the Chinese fertile women was 29 (range 22-38) years, whereas the mean age of the Caucasian women was 36 (range 30-42) years. None of the fertile controls had a history of spontaneous miscarriage. In the recurrent miscarriage group, the mean number of miscarriages was 3 (range 3-5) and the mean age was 35 (range 26-40) years. In the recurrent implantation failure group, the mean number of failed IVF cycles was 4 (range 3-6) and the mean age was 37 (range 32-40) years. Figure 1 shows the immunohistochemical staining for CD56 þ cells, which were present as individual or group cells throughout the stroma in selective LHþ7 endometrium from fertile women, women with recurrent miscarriage, and women with recurrent implantation failure. Visual examination suggested that an increased percentage of CD56
Staining patterns
þ cells was present in the endometrium from women with recurrent miscarriage and women with recurrent implantation failure, compared with controls. These observations were confirmed by further statistical analysis.
Intraobserver and interobserver variability
Intraobserver and interobserver variability for uNK cell percentage is summarized in Table 2 . Regarding intraobserver variability, 1 observer measured the percentage of uNK cells in 23 biopsies on 2 separate occasions. There was significant correlation (r ¼ 0.96, P < .001) between the percentage of cells counted on each occasion. The median uNK cells expressed as a percentage of the total stromal cells in the specimens was: measurement A, 2.70% (range 0.60-8.50%) and measurement B, 2.67% (range 0.60-8.40%), respectively. The coefficient of variance for intraobserver measurement was 9.9%.
For interobserver variability, the same set of 23 specimens was measured by 2 
uNK cell percentage in fertile women
The median uNK cell percentage from 72 Chinese fertile controls was 2.5% (range 0.9-5.3%). We decided to use the 5th and 95th percentile results in periimplantation endometrium from these ovulatory fertile Chinese women in natural cycles as our reference range, which gave a reference range of uNK cell percentage from 1.2-4.5%.
The median uNK cell percentage from 12 Caucasian normal fertile women in natural cycles was 3.3% (range 1.1-5.3%). There was no significant difference in uNK cell percentage between fertile Chinese and Caucasian women.
uNK cell percentage in women with recurrent reproductive failure
The median uNK cell percentage in the women with recurrent miscarriage was 3.2% (range 0.6-8.8%), and in the women with recurrent implantation failure was 3.1% (range 0.8-8.3%). Compared to the median result in the fertile controls (2.5%), there was a significantly increased percentage of uNK cells observed in women with recurrent miscarriage (P ¼ .042), as well as women with recurrent implantation failure (P ¼ .048).
Using the 5th percentile (1.2%) as the lower limit and 95th percentile (4.5%) as the upper limit to define the reference range of uNK cell percentage, 60 of the 97 (around 62%) women with recurrent miscarriage were within the reference range, with 21 women above the range and 16 women below the range. In women with recurrent implantation failure, 18 of the 34 (around 53%) women had uNK cell percentage within the reference range, with 10 women above the range and 6 women below the range (Figure 2 ).
Comment
In this study, we established a reference range for uNK cell percentage in periimplantation endometrium using the 5th and 95th percentile results for a group of Chinese fertile women. We also observed a significantly increased uNK cell percentage in women with recurrent reproductive failure. In addition, only around 62% of the women with recurrent miscarriage and around 53% of the women with recurrent implantation failure had uNK cell percentage within the established reference range.
Methods for uNK cells testing
A lack of a standardized method for the measurement of uNK cell percentage has been considered a hindrance to the progress in understanding the role of these cells in pregnancy. However, the recent publication of a working group, 10 which addressed a standardized protocol for the timing of sampling, processing of specimens, as well as the counting method including the magnification and the number of fields/cells to be counted has started to resolve this process. In this study, we adopted this standardized methodology and verified its use by performing interobserver variation analysis using people from 2 separate laboratories in 2 different countries. The analysis showed acceptable levels of variation.
In the current study, the result for uNK cell measurement was expressed as a percentage (number of CD56 þ /stromal cells) rather than the absolute number of uNK cells per microscopic field, because the latter presenting method does not take into account the relative size of the field, the presence of variable amounts of glandular components and blood vessels, or the amount of edema in the stroma. The presentation of uNK cell measurement as a percentage is in line with recommendations on the standardization of uNK cell measurement. 10 Given the very rapid changes in endometrial morphology and function around the time of implantation and that the number of uNK cells increases rapidly as the menstrual cycle progresses, 13, 14 it is important that biopsies are precisely timed. In this study, biopsies from all women were precisely timed to take place at LHþ7. We accept that it is not always possible to collect a Reference range for uNK cell Despite many publications on uNK cell numbers, there is a lack of sufficiently robust data on the reference range derived from fertile subjects with which women with various reproductive failures can be compared. Our study has shown that the reference range of uNK cell percentage in endometrium from the ovulatory fertile Chinese population in natural cycles can be defined as 1.2%-4.5%. However, the findings may not apply to cycles employing controlled ovarian stimulation or in cycles with programmed frozen embryo transfer.
As far as we are aware, the number of Chinese fertile controls in our study (n ¼ 72) presents the largest series published and is considerably larger than previous studies from 2 different centers. These studies using small numbers of control women (n ¼ 18 and n ¼ 13, respectively) defined a high cell percentage as 5% and 12.9%. The study by Quenby et al 9 defined "high" as the 75th percentile of the control population, while Tuckerman et al 5 used a cut-off of 90th percentile. In this study, we chose to use 5th and 95th percentiles to define the lower and upper limits in accordance with general recommended protocol. This gave an upper limit of 4.5% uNK cells, which is similar to that reported by Quenby et al. 9 In addition, all previous studies focused on the upper limit of the reference range without attention to what may be the lower limit due to the assumption that high uNK cell percentage is detrimental to the reproductive process. Limited attention had been paid to "low uNK cell" and the possible adverse impact of too few uNK cells on the endometrium. Based on our proposed reference range, we defined a lower limit of 1.2% and found that around 16% (16/97) of women with recurrent miscarriage and around 18% (6/34) of women with recurrent implantation failure had uNK cell percentage below this value. The clinical relevance of this observation requires further investigations.
uNK cells and recurrent reproductive failure
Several studies have shown no significant difference in uNK cell percentage between women with recurrent miscarriage and fertile women, 15, 16 whereas the majority of studies have found increased percentage of uNK cells in the endometrium from women with recurrent miscarriage. [3] [4] [5] This study, which is consistent with many of the earlier studies, has shown that median uNK cell percentage was increased in women with recurrent miscarriage. Around 22% (21/97) of women with recurrent miscarriage had a high uNK cell percentage as defined by our suggested upper limit.
An earlier study found no increase in uNK cell percentage in young women with recurrent implantation failure. 17 However, several other studies have reported an increase in uNK cell percentage in endometrium from women with recurrent implantation failure after IVF. 6, 7 In this study, we also found a significantly increased percentage of uNK cells in women with recurrent implantation failure when compared to fertile controls, with around 29% (10/ 34) of these women having uNK cell percentage above the upper limit.
Comparison between ethnic groups
An earlier study compared peripheral NK cells between Chinese and Caucasian populations and found that the number of peripheral NK cell in Chinese women was higher than in Caucasian women. 18 However, to our knowledge, there has not been any study reporting on the variation of uNK cells in various ethnic groups to date.
In this study, the median and range of uNK cell percentages in Chinese and Caucasian fertile women were similar and the reference range established could be applied to both ethnic groups. However, the number of Caucasian women was very small in this study and a larger sample size is needed to confirm this observation.
Strengths of this study
There are several strengths to our study. Firstly, we included only precisely timed endometrial biopsies on LHþ7 in natural cycles. Secondly, we had used a standardized protocol of immunostaining and cell counting method to obtain numbers of uNK cells. Thirdly, we recruited a large group of 72 fertile Chinese women to establish the reference range, which is considerably larger than that of previous studies.
Role of uNK cells in the endometrium
Although a precise role for uNK cells in endometrial function and embryo implantation is not clear, a recent review highlighted their possible role in effective implantation by controlling the depth and pattern of trophoblast invasion. 19 There is also evidence for a role of uNK cells in other important events in the endometrium and decidua, such as the control of vascular remodeling in early pregnancy. 20 In vitro models have shown that uNK cell supernatants can alter markers of vascular remodeling. 20 Moreover, uNK cells were observed to be frequently aggregated around the spiral arteries in early pregnancy and this distribution may reflect their role in mediating vascular changes in normal pregnancy. 21 
Conclusion
In this study, we established a reference range for uNK cell percentage in periimplantation endometrium on day LHþ7 in fertile women and, using this reference range, found that a significant proportion of women with recurrent reproductive failure had uNK cell percentages both above and below the reference range. We found that around 38% of women with recurrent miscarriage and around 47% of women with recurrent implantation failure had uNK cell count outside the reference range, with a majority above the range and a smaller proportion below the range. n
